Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a
leading cause of cancer-related death worldwide. In the United States, HCC is the ninth …

The intermediate stage of hepatocellular carcinoma (HCC) comprises a highly
heterogeneous patient population and therefore poses unique challenges for therapeutic …

Background Liver hepatocellular carcinoma (LIHC) ranks sixth among the most common
types of cancer with a high mortality rate. Cuproptosis is a newly discovered type of cell …

Exosomal noncoding RNAs (ncRNAs) have unique expression profiles reflecting the
characteristics of a tumor, and their role in tumor progression and metastasis is emerging …

Background Patients undergoing liver transplantation for hepatocellular carcinoma within
the Milan criteria (single tumour≤ 5 cm in size or≤ 3 tumours each≤ 3 cm in size, and no …

BACKGROUND/AIMS: To characterize IL-17-producing cells, a newly defined T helper cell
subset with potent pro-inflammatory properties, in hepatocellular carcinoma (HCC) and to …

Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver. Its
relationship to chronic liver diseases, in particular cirrhosis, develops on a background of …

BACKGROUND & AIMS: Tumor cells survive hypoxic conditions by inducing autophagy. We
investigated the roles of microRNAs (miRNAs) in regulating autophagy of hepatocellular …

Inhibition of programmed cell death is considered to be a major aspect of tumorigenesis.
Indeed, several key oncogenic transcription factors, such as NF-κB and STAT3, exert their …

Background: Application of curative therapy for hepatocellular carcinoma is crucially
dependent on underlying liver function. Using the recently described ALBI grade we …